PHEX mutation was confirmed in 17 (53.1%) patients with non-hyperparathyroidism, 17 (51.5%) patients with secondary hyperparathyroidism, and 2 (50.0%) patients with tertiary hyperparathyroidism. The gene discussed is PHEX; the disease is secondary hyperparathyroidism.